← Leaderboards
Hamideh Parhiz
Fred Hutchinson Cancer Center
$2,983,672
Attributed
$5,967,344
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2023–25$2.5M$1.9M$1.3M$625K$0
'23
'24
'25
Funding mix
By agency
NIH$5,967,344 · 3
By mechanism
R01$5,967,344 · 3
Top collaborators
- Jacob Brenner3 shared
- James L Riley3 shared
- Christopher W Peterson2 shared
Most similar at Fred Hutchinson Cancer Center
Same institution · by research overlap
- Hans-Peter Kiem$98,160,227
- Joshua Aiden Hill$6,198,358
- Denise A. Galloway$30,691,532
- Christopher W Peterson$4,927,751
- A. McGarry Houghton$19,684,845
Others in their field
Other Rising Stars on “In Vivo”
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Sabrina Paganoni · Massachusetts General Hospital$17,050,216
- Suma Babu · Massachusetts General Hospital$17,050,216
- Kevin V Grimes · Stanford University$14,783,804
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
Research focus
In VivoAntibodiesMessenger RnaTechnologyCovid-19 VaccineFda ApprovedLipid NanoparticleSuccessMonocyteEncapsulatedDesignProteinsCell TypeAntiretroviral TherapyCell PhysiologyImmuneNanoparticle DeliveryEnvironmentDoseExperimental StudyClinicCd4 Positive T LymphocytesAnimal ModelClinical Trials
Grant awards (8)
Eliminating the latent reservoir by targeted in vivo delivery of HIV-specific CARs$758,836
R01 · FY2025 · AI
mRNA-LNPs for ARDS$683,436
R01 · FY2025 · HL · contact PI
Developing Durable, Env-Boosted CAR T Cells for HIV Cure$849,858
R01 · FY2024 · AI
Eliminating the latent reservoir by targeted in vivo delivery of HIV-specific CARs$718,306
R01 · FY2024 · AI
mRNA-LNPs for ARDS$694,692
R01 · FY2024 · HL · contact PI
Developing Durable, Env-Boosted CAR T Cells for HIV Cure$893,464
R01 · FY2023 · AI
Eliminating the latent reservoir by targeted in vivo delivery of HIV-specific CARs$689,181
R01 · FY2023 · AI
mRNA-LNPs for ARDS$679,571
R01 · FY2023 · HL · contact PI